Page 635 - Read Online

Peyvandi et al. J Cancer Metastasis Treat 2019;5:44 I http://dx.doi.org/10.20517/2394-4722.2019.16 Page 23 of 24

222. Luen SJ, Savas P, Fox SB, Salgado R, Loi S. Tumour-infiltrating lymphocytes and the emerging role of immunotherapy in breast cancer.
Pathology 2017;49:141-55.
223. Ma Y, Adjemian S, Yang H, Catani JP, Hannani D, et al. ATP-dependent recruitment, survival and differentiation of dendritic cell
precursors in the tumor bed after anticancer chemotherapy. Oncoimmunology 2013;2:e24568.
224. Ma Y, Adjemian S, Mattarollo SR, Yamazaki T, Aymeric L, et al. Anticancer chemotherapy-induced intratumoral recruitment and
differentiation of antigen-presenting cells. Immunity 2013;38:729-41.
225. Acharyya S, Oskarsson T, Vanharanta S, Malladi S, Kim J, et al. A CXCL1 paracrine network links cancer chemoresistance and
metastasis. Cell 2012;150:165-78.
226. Lan Q, Peyvandi S, Duffey N, Huang YT, Barras D, et al. Type I interferon/IRF7 axis instigates chemotherapy-induced immunological
dormancy in breast cancer. Oncogene 201810.1038/s41388-018-0624-2.
227. Sistigu A, Yamazaki T, Vacchelli E, Chaba K, Enot DP, et al. Cancer cell-autonomous contribution of type I interferon signaling to the
efficacy of chemotherapy. Nat Med 2014;20:1301-9.
228. Legrier ME, Bieche I, Gaston J, Beurdeley A, Yvonnet V, et al. Activation of IFN/STAT1 signalling predicts response to chemotherapy in
oestrogen receptor-negative breast cancer. Br J Cancer 2016;114:177-87.
229. Sisirak V, Faget J, Gobert M, Goutagny N, Vey N, et al. Impaired IFN-alpha production by plasmacytoid dendritic cells favors regulatory
T-cell expansion that may contribute to breast cancer progression. Cancer Res 2012;72:5188-97.
230. Ignatiadis M, Singhal SK, Desmedt C, Haibe-Kains B, Criscitiello C, et al. Gene modules and response to neoadjuvant chemotherapy in
breast cancer subtypes: a pooled analysis. J Clin Oncol 2012;30:1996-2004.
231. Desmedt C, Haibe-Kains B, Wirapati P, Buyse M, Larsimont D, et al. Biological processes associated with breast cancer clinical outcome
depend on the molecular subtypes. Clin Cancer Res 2008;14:5158-65.
232. Bidwell BN, Slaney CY, Withana NP, Forster S, Cao Y, et al. Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis
through immune escape. Nat Med 2012;18:1224-31.
233. Liu Y, Lv J, Liu J, Liang X, Jin X, et al. STAT3/p53 pathway activation disrupts IFN-beta-induced dormancy in tumor-repopulating cells.
J Clin Invest 2018;128:1057-73.
234. Dunn GP, Koebel CM, Schreiber RD. Interferons, immunity and cancer immunoediting. Nat Rev Immunol 2006;6:836-48.
235. Muller-Hermelink N, Braumuller H, Pichler B, Wieder T, Mailhammer R, et al. TNFR1 signaling and IFN-gamma signaling determine
whether T cells induce tumor dormancy or promote multistage carcinogenesis. Cancer Cell 2008;13:507-18.
236. Dormond O, Lejeune FJ, Ruegg C. Modulation of cdk2, cyclin D1, p16INK4a, p21WAF and p27Kip1 expression in endothelial cells by
TNF/IFN gamma. Anticancer Res 2002;22:3159-63.
237. Retsky MW, Demicheli R, Hrushesky WJ, Baum M, Gukas ID. Dormancy and surgery-driven escape from dormancy help explain some
clinical features of breast cancer. APMIS 2008;116:730-41.
238. Retsky M, Demicheli R, Hrushesky W, Baum M, Gukas I. Surgery triggers outgrowth of latent distant disease in breast cancer: an
inconvenient truth? Cancers (Basel) 2010;2:305-37.
239. Kelsey CR, Fornili M, Ambrogi F, Higgins K, Boyd JA, et al. Metastasis dynamics for non-small-cell lung cancer: effect of patient and
tumor-related factors. Clin Lung Cancer 2013;14:425-32.
240. Demicheli R, Fornili M, Ambrogi F, Higgins K, Boyd JA, et al. Recurrence dynamics for non-small-cell lung cancer: effect of surgery on
the development of metastases. J Thorac Oncol 2012;7:723-30.
241. Hanin L, Bunimovich-Mendrazitsky S. Reconstruction of the natural history of metastatic cancer and assessment of the effects of surgery:
Gompertzian growth of the primary tumor. Math Biosci 2014;247:47-58.
242. Dillekas H, Demicheli R, Ardoino I, Jensen SA, Biganzoli E, et al. The recurrence pattern following delayed breast reconstruction
after mastectomy for breast cancer suggests a systemic effect of surgery on occult dormant micrometastases. Breast Cancer Res Treat
2016;158:169-78.
243. Van Dierendonck JH, Keijzer R, Cornelisse CJ, Van de Velde CJ. Surgically induced cytokinetic responses in experimental rat mammary
tumor models. Cancer 1991;68:759-67.
244. Abramovitch R, Marikovsky M, Meir G, Neeman M. Stimulation of tumour angiogenesis by proximal wounds: spatial and temporal
analysis by MRI. Br J Cancer 1998;77:440-7.
245. Gunduz N, Fisher B, Saffer EA. Effect of surgical removal on the growth and kinetics of residual tumor. Cancer Res 1979;39:3861-5.
246. Krall JA, Reinhardt F, Mercury OA, Pattabiraman DR, Brooks MW, et al. The systemic response to surgery triggers the outgrowth of
distant immune-controlled tumors in mouse models of dormancy. Sci Transl Med 2018;10.
247. Danish HH, Goyal S, Taunk NK, Wu H, Moran MS, et al. Interferon-induced protein with tetratricopeptide repeats 1 (IFIT1) as a
prognostic marker for local control in T1-2 N0 breast cancer treated with breast-conserving surgery and radiation therapy (BCS + RT).
Breast J 2013;19:231-9.
248. De Cock JM, Shibue T, Dongre A, Keckesova Z, Reinhardt F, et al. Inflammation triggers Zeb1-dependent escape from tumor latency.
Cancer Res 2016;76:6778-84.
249. Albrengues J, Shields MA, Ng D, Park CG, Ambrico A, et al. Neutrophil extracellular traps produced during inflammation awaken
dormant cancer cells in mice. Science 2018;361.
250. Okubo M, Kioi M, Nakashima H, Sugiura K, Mitsudo K, et al. M2-polarized macrophages contribute to neovasculogenesis, leading to
relapse of oral cancer following radiation. Sci Rep 2016;6:27548.
251. Machida H, De Zoysa MY, Takiuchi T, Hom MS, Tierney KE, et al. Significance of monocyte counts at recurrence on survival outcome
of women with endometrial cancer. Int J Gynecol Cancer 2017;27:302-10.
252. Bowers LW, Maximo IX, Brenner AJ, Beeram M, Hursting SD, et al. NSAID use reduces breast cancer recurrence in overweight and
obese women: role of prostaglandin-aromatase interactions. Cancer Res 2014;74:4446-57.
253. Pierce BL, Ballard-Barbash R, Bernstein L, Baumgartner RN, Neuhouser ML, et al. Elevated biomarkers of inflammation are associated